Alexander J. Denner, Ph.D.

Sarissa Capital Management Lp

Assets Managed

$157.637M

Holdings

Last Quarter

2026 - Q1

Filed Date

27d ago

Growth Rate

-29.28%(2Q avg: -2.85%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sarissa Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 9 positions.

Assets under management

The assets under management (AUM) of Sarissa Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 157.637M in assets, with a quarterly growth rate of -29.28% and a 2-quarter average growth rate of -2.85%. The portfolio is managed by Alexander J. Denner, Ph.D., and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
INVA Innoviva Inc Recent Activity Decreased -24.32%	31.5%	$49.651M 2.131M shares@ $23.3 avg price	Decreased -24.32%
IRWD Ironwood Pharmaceuticals Inc Recent Activity Decreased -42.28%	20.46%	$32.252M 9.189M shares@ $3.52 avg price	Decreased -42.28%
AMRN Amarin Corp Plc -adr Recent Activity	15.36%	$24.197M 1.673M shares@ $14.47 avg price
NBIX Neurocrine Biosciences Inc Recent Activity Decreased -61.55%	9.74%	$15.352M 116,533 shares@ $131.74 avg price	Decreased -61.55%
CYTK Cytokinetics Inc Recent Activity Decreased -42.31%	9.56%	$15.069M 228,623 shares@ $65.92 avg price	Decreased -42.31%
LNTH Lantheus Holdings Inc Recent Activity Decreased -8%	8.04%	$12.661M 166,919 shares@ $75.85 avg price	Decreased -8%
BHVN Biohaven Ltd Recent Activity Increased 9.75%	3.03%	$4.765M 563,184 shares@ $8.47 avg price	Increased 9.75%
REGN Regeneron Pharmaceuticals Recent Activity	2.06%	$3.237M 4,190 shares@ $772.65 avg price
VOR Vor Biopharma Inc Recent Activity	0.29%	$453,118 25,399 shares@ $17.84 avg price

1-9 of 9